XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies - Summary of Accrued expense (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Compensation $ 1,937 $ 3,355
Clinical study related costs 1,247 1,636
Facility Expansion Costs 435 0
Accrued legal costs 606 436
Manufacturing improvement costs 841 678
Accrued consulting and professional fees 1,338 1,210
Other accrued expenses 450 21
Total accrued expenses and other $ 6,854 $ 7,336